Barbara A. Prillaman

1.6k total citations
38 papers, 1.2k citations indexed

About

Barbara A. Prillaman is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Barbara A. Prillaman has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Physiology, 24 papers in Pulmonary and Respiratory Medicine and 14 papers in Immunology and Allergy. Recurrent topics in Barbara A. Prillaman's work include Asthma and respiratory diseases (30 papers), Respiratory and Cough-Related Research (18 papers) and Allergic Rhinitis and Sensitization (14 papers). Barbara A. Prillaman is often cited by papers focused on Asthma and respiratory diseases (30 papers), Respiratory and Cough-Related Research (18 papers) and Allergic Rhinitis and Sensitization (14 papers). Barbara A. Prillaman collaborates with scholars based in United States, Australia and Denmark. Barbara A. Prillaman's co-authors include Tushar Shah, Karen House, Leslie Baitinger, E. Philpot, Gary N. Gross, James Wolfe, Julian Melamed, Craig LaForce, Mani S. Kavuru and Melissa Faris and has published in prestigious journals such as New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine and PEDIATRICS.

In The Last Decade

Barbara A. Prillaman

37 papers receiving 1.1k citations

Peers

Countries citing papers authored by Barbara A. Prillaman

Since Specialization

Citations

This map shows the geographic impact of Barbara A. Prillaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Prillaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Prillaman more than expected).

Fields of papers citing papers by Barbara A. Prillaman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara A. Prillaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Prillaman. The network helps show where Barbara A. Prillaman may publish in the future.

Co-authorship network of co-authors of Barbara A. Prillaman

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara A. Prillaman. A scholar is included among the top collaborators of Barbara A. Prillaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara A. Prillaman. Barbara A. Prillaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Undiagnosed OSA May Significantly Affect Outcomes in Adults Admitted for COPD in an Inner-City Hospital 2020 ·CHEST Journal ·Mario Naranjo, Leslee Willes, Barbara A. Prillaman, Stuart F. Quan, Sunil Sharma	39
2	Sleep Disordered Breathing in Hospitalized African-Americans 2020 ·Journal of the National Medical Association ·(unknown), (unknown), Barbara A. Prillaman, Leslee Willes, (unknown), (unknown), (unknown), Sunil Sharma	5
3	Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma 2016 ·New England Journal of Medicine ·David A. Stempel, Stanley J. Szefler, Søren Pedersen, Robert S. Zeiger, Anne Yeakey, Laurie A. Lee, Andrew H. Liu, Herman Mitchell, Kenneth M. Kral, Ibrahim Raphiou, Barbara A. Prillaman, (unknown), Suyong Yun Kirby, Steven Pascoe	77
4	The association between seasonal asthma exacerbations and viral respiratory infections in a pediatric population receiving inhaled corticosteroid therapy with or without long-acting beta-adrenoceptor agonist: A randomized study 2015 ·Respiratory Medicine ·Charlene M. Prazma, James E. Gern, Steven F. Weinstein, Barbara A. Prillaman, David A. Stempel	10
5	Prevalence of Airway Obstruction Assessed by Lung Function Questionnaire 2011 ·Mayo Clinic Proceedings ·Matthew L. Mintz, Barbara P. Yawn, David M. Mannino, James F. Donohue, Nicola A. Hanania, (unknown), Alicia Gilsenan, Lori McLeod, Anand A. Dalal, Ibrahim Raphiou, Barbara A. Prillaman, Glenn Crater, Michael J. Cicale, Douglas W. Mapel	20
6	Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study 2010 ·Annals of Allergy Asthma & Immunology ·Eli O. Meltzer, Charles P. Andrews, (unknown), (unknown), Barbara A. Prillaman, Cindy Garris, E. Philpot	15
7	Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma? 2008 ·Respiratory Medicine ·Steven M. Koenig, John Murray, James Wolfe, (unknown), Steve Yancey, Barbara A. Prillaman, John L. Stauffer, Paul Dorinsky	22
8	Deterioration in Asthma Control When Subjects Receiving Fluticasone Propionate/Salmeterol 100/50 mcg Diskus are “Stepped-Down” 2008 ·Journal of Asthma ·Steven M. Koenig, Nancy K. Ostrom, David S. Pearlman, (unknown), Steven W. Yancey, Barbara A. Prillaman, Paul Dorinsky	33
9	Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: A randomized, multicenter, double-blind, single-dose, crossover study 2008 ·Clinical Therapeutics ·Eli O. Meltzer, (unknown), Jeffrey Leflein, (unknown), (unknown), Anand A. Dalal, Barbara A. Prillaman, E. Philpot	21
10	Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms 2006 ·Annals of Allergy Asthma & Immunology ·(unknown), Charles P. Andrews, (unknown), Frank C. Hampel, (unknown), Barbara A. Prillaman, Melissa Faris, E. Philpot	40
11	Measuring Airway Hyperresponsiveness: Does it Add to Routine Measures of Clinical Efficacy in Guiding Asthma Therapy? 2006 ·Journal of Allergy and Clinical Immunology ·John L. Stauffer, Steven W. Yancey, Leslie Baitinger, Barbara A. Prillaman, Paul Dorinsky	0
12	Fluticasone Propionate Nasal Spray Is Superior to Montelukast for Allergic Rhinitis While Neither Affects Overall Asthma Control 2005 ·CHEST Journal ·Robert A. Nathan, Steven W. Yancey, (unknown), Barbara A. Prillaman, John L. Stauffer, E. Philpot, Paul Dorinsky, Harold S. Nelson	32
13	Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function. 2004 ·PubMed ·Ketan Sheth, Cindy K. Cook, E. Philpot, Barbara A. Prillaman, (unknown), Melissa Faris, (unknown), Kathleen Rickard	16
14	Improved Ability to Perform Strenuous Activities After Treatment with Fluticasone Propionate/Salmeterol Combination in Patients with Persistent Asthma 2003 ·Journal of Asthma ·Robert A. Nathan, Paul Dorinsky, Jacqueline R. Carranza Rosenzweig, Tushar Shah, Heather M. Edin, Barbara A. Prillaman	19
15	Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma 2000 ·American Journal of Respiratory and Critical Care Medicine ·Gail Shapiro, William R. Lumry, James Wolfe, John Given, Martha V. White, (unknown), Leslie Baitinger, Karen House, Barbara A. Prillaman, Tushar Shah	176
16	Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial 2000 ·Journal of Allergy and Clinical Immunology ·Mani S. Kavuru, Julian Melamed, Gary N. Gross, Craig LaForce, Karen House, Barbara A. Prillaman, Leslie Baitinger, (unknown), Tushar Shah	199
17	Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by Diskus device in patients with asthma treated with or without inhaled corticosteroids 2000 ·Journal of Allergy and Clinical Immunology ·James Wolfe, Anthony R. Rooklin, James J. Grady, Zev M. Munk, Anne M. Stevens, Barbara A. Prillaman, Susan P. Duke, Stuart M. Harding	30
18	Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma 1999 ·Annals of Allergy Asthma & Immunology ·David S. Pearlman, W. Stricker, Steven F. Weinstein, Gary N. Gross, Paul Chervinsky, (unknown), Barbara A. Prillaman, Tushar Shah	86
19	Single-Dose Ondansetron Prevents Postoperative Vomiting in Pediatric Outpatients 1997 ·Anesthesia & Analgesia ·Ramesh I. Patel, Peter J. Davis, Rosemary J. Orr, Lynne R. Ferrari, Stephen Rimar, Raafat S. Hannallah, Ira Todd Cohen, (unknown), John V. Donlon, Charles M. Haberkern, Francis X. McGowan, Barbara A. Prillaman, T.V. Parasuraman, Mary R. Creed	32
20	Intravenous Ondansetron in Established Postoperative Emesis in Children 1996 ·Anesthesiology ·Samia N. Khalil, Alexander Rodarte, (unknown), Michael Weinstein, Zvi Grunwald, Brian Ginsberg, Robert Kaye, (unknown), Melissa Wheeler, (unknown), Barbara A. Prillaman, Mary R. Creed	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact